Developer docs
API playgroundTry for free, no card

Search company profiles

Teora

Full company profile

uuid00037kw

Namestring
Teora
Legal namestring
Teora Pte. Ltd
Websiteurl
teoralife.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Teora is a Singapore-headquartered biotech company that designs and delivers AI-engineered, feed-based oral biologics for animal disease management and growth enhancement. Its SOLAQ™ platform combines proprietary bioinformatics, synthetic biology, precision fermentation, and microencapsulation to produce room-temperature-stable, species-specific products that replace antibiotics, injections, and cold-chain-dependent vaccines across aquaculture, with planned expansion into livestock, poultry, crops, and companion animals.

The company sells its products under trademarked sub-brands including ShrimpGuard™ and FishGuard™ (prophylactic disease protection), FishJumbo™ (growth enhancement), and the ShrimpTrident™ family (therapeutic intervention against WSSV, Vibrio, EHP, and IMNV in shrimp). Field-validated across 5 Southeast Asian countries with 10+ independent trials, Teora reports outcomes of up to 90% survival in shrimp and fish, 70% antibiotic reduction, 20% faster growth, and 0.2–0.5 FCR improvement. The platform compresses biologic development cycles from 3–5 years to 6–8 months.

Teora generates revenue through transactional biologic product sales to aquaculture farmers, feed mills, and distributors, supplemented by licensing partnerships, co-development arrangements, and distributor/reseller margins. Pricing is quote-based and volume-tiered. The company is privately held and venture-backed, with disclosed funding of approximately ~$2.0–2.3M spanning grants (Temasek Foundation, The Liveability Challenge, Alberta Innovates), angel (Investible), VC (PeakBridge), and accelerator backing (Entrepreneur First, Berkeley SkyDeck, Hatch). Operations span Singapore HQ and a Bangalore, India field operations office supporting South Asia trials and partnerships.

Short descriptiontext

Teora is a Singapore-based biotech that designs AI-engineered, feed-based oral biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) for aquaculture disease management and growth enhancement, with planned expansion into livestock, poultry, and crops.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aquaculture animal health, oral biologics platform, feed-based disease prevention, synthetic biology solutions, precision fermentation biologics
Industry4 codes
PRIMARYAFADADAI
Functional & Health Aquaculture Feed (Immunity, Disease Mitigation)
SECONDARYHLAMAHAF
Aquaculture Feed & Nutrition
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
SECONDARYAFADAGAN
Carrier Systems & Microencapsulated Additive Premixes (Protected Nutrients, Slow-Release)
Agriculture & Food Production/Animal Feed Manufacturing/Feed Premixes & Concentrates (Vitamins, Minerals, Additives)
SECONDARYAFADADAF
Broodstock & Breeder Feed
NAICS code2 codes
  • Other Animal Food Manufacturing311119
  • Animal Food Manufacturing3111
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Aquaculture Biologics
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Biologic Product Sales (Aquaculture)
TypeOne Time License
Description

Sale of feed-based biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) to aquaculture farmers, feed mills, and distributors. Products are sold as top-coated feed additives or standalone powders. Revenue is transactional with recurring purchase dynamics driven by farm cycle needs.

teoralife.com
2Licensing Partnerships
TypeLicensing Royalties
Description

Teora offers licensing partnerships for its technology platform, enabling other companies to access SOLAQ™ biologics for specific species, regions, or applications.

teoralife.com
3Co-Development & Custom Solutions
TypeProfessional Services
Description

Custom biologic development partnerships with feed mills, distributors, or large farming operations requiring species or pathogen-specific solutions. Revenue generated through development fees and subsequent product supply.

teoralife.com
4Distribution & Reseller Revenue
TypeTransaction Fee
Description

Revenue through distributor and reseller networks that stock and sell Teora biologics to end-user farmers, with margins earned on product throughput.

teoralife.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Volume-based pricing for smallholder and industrial farms
ModelUnit PricingBilling cadencePay-as-you-go
Notes

ShrimpGuard Grow-out: 1% (10 g/kg feed), 3 consecutive days weekly. Hatchery: 2% (20 g/kg feed), 5 consecutive days monthly. Pricing likely varies by volume, species, and partnership arrangement.

teoralife.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1ShrimpGuard
Description

Feed-based multi-peptide biologic that primes shrimp innate immunity against viral and bacterial challenges including WSSV, IMNV. Available as ShrimpGuard Hatchery and ShrimpGuard Grow-out.

teoralife.com
+3 more records
Core offering1 text field

Teora develops and manufactures disease management and growth enhancement solutions for aquaculture and livestock farming through its proprietary SOLAQ™ AI-powered biotech platform. The platform combines AI-driven bioinformatics, synthetic biology, precision fermentation, and advanced microencapsulation to produce feed-based oral biologics—multi-peptide and microRNA products applied as top-coated feed additives that replace antibiotics, traditional vaccines, and injection-based treatments. Core products include ShrimpGuard™, FishGuard™, FishJumbo™, and ShrimpTrident™ (with variants targeting WSSV, Vibrio, EHP, and IMNV pathogens), sold to shrimp and fish farmers, feed mills, and distributors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 12 values shown
  • Up to 90% survival in shrimp farms (vs 0-30% untreated control)
+11 more records
Product overview1 text field

Teora offers SOLAQ™, an AI-powered biotech platform that delivers clean, feed-integrated biologics for disease management and growth enhancement across aquaculture, livestock, poultry, companion animals and agriculture. The platform is built around two core product lines: the GUARD SERIES (ShrimpGuard™ and FishGuard™) providing prophylactic disease protection, and the JUMBO SERIES (FishJumbo™) for growth optimization. Additionally, ShrimpTrident variants (SPOT, VIB, EH, MYO) provide targeted therapeutic interventions for specific shrimp pathogens. All products are feed-based, room-temperature stable, antibiotic-free, and designed for direct integration into existing farm operations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Phibro operates a dedicated aquaculture health portfolio (including vaccines and treatments for shrimp and fish pathogens) sold through similar B2B channels to integrators and feed mills. Teora competes most directly with Phibro's health products in SE Asian shrimp and fish farms.

2INVE Aquaculture (Benchmark Holdings)
TypeDirect peer
Description

INVE offers health and nutrition products for aquaculture hatcheries and grow-out operations, including probiotics and disease-management solutions for shrimp and fish. Like Teora, INVE targets the same species and farm-vertical customers in SE Asia.

TypeEmerging player
Description

Veramaris produces alternative, sustainable nutrition ingredients (algal omega-3) for aquaculture feed, addressing similar sustainability and residue-free positioning as Teora. Comparable in being a science-led, feed-based aquaculture solutions company targeting premium feed mills.

TypeBroad incumbent
Description

Alltech is a global animal nutrition and health company with aquaculture-specific products, including probiotics and feed additives. Teora competes for share of feed-mill biologics and species-specific solutions across the same customer base.

5Lallemand Animal Nutrition
TypeDirect peer
Description

Lallemand provides probiotics, yeast derivatives, and microbial feed additives across aquaculture and livestock, with comparable B2B feed-mill and farmer channel relationships. Teora's peptide and RNAi biologics are a higher-precision alternative to Lallemand's microbial solutions.

TypeBroad incumbent
Description

Elanco is a global animal health giant with a substantial aquaculture portfolio including vaccines and therapeutics. As a large incumbent with established regulatory dossiers and distribution, Elanco represents the most credible large-player threat to Teora's positioning.

TypeBroad incumbent
Description

Merck/MSD Animal Health is a global leader in aquaculture vaccines and health products. Comparable in targeting disease management in shrimp and fish but with established scale, capital, and regulatory reach that Teora must compete against.

TypeOthers
Description

BioMar is a major aquaculture feed manufacturer that increasingly incorporates health and functional ingredients into its feeds. BioMar is both a potential channel partner and a competitor for functional feed-additive share.

TypeOthers
Description

Skretting is the world's largest aquaculture feed producer with active development of functional and health-focused feed lines. Skretting represents both a major distribution channel opportunity and a potential competitor for premium feed positioning.

TypeBroad incumbent
Description

Virbac is a global animal health company with aquaculture products spanning vaccines, anti-infectives, and nutrition. Comparable in targeting health outcomes in farmed species through veterinary biologics, but operating at much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teora

Aquaculture Biologicsteoralife.com

Teora is a Singapore-based biotech that designs AI-engineered, feed-based oral biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) for aquaculture disease management and growth enhancement, with planned expansion into livestock, poultry, and crops.

What Teora does

Teora is a Singapore-headquartered biotech company that designs and delivers AI-engineered, feed-based oral biologics for animal disease management and growth enhancement. Its SOLAQ™ platform combines proprietary bioinformatics, synthetic biology, precision fermentation, and microencapsulation to produce room-temperature-stable, species-specific products that replace antibiotics, injections, and cold-chain-dependent vaccines across aquaculture, with planned expansion into livestock, poultry, crops, and companion animals.

The company sells its products under trademarked sub-brands including ShrimpGuard™ and FishGuard™ (prophylactic disease protection), FishJumbo™ (growth enhancement), and the ShrimpTrident™ family (therapeutic intervention against WSSV, Vibrio, EHP, and IMNV in shrimp). Field-validated across 5 Southeast Asian countries with 10+ independent trials, Teora reports outcomes of up to 90% survival in shrimp and fish, 70% antibiotic reduction, 20% faster growth, and 0.2–0.5 FCR improvement. The platform compresses biologic development cycles from 3–5 years to 6–8 months.

Teora generates revenue through transactional biologic product sales to aquaculture farmers, feed mills, and distributors, supplemented by licensing partnerships, co-development arrangements, and distributor/reseller margins. Pricing is quote-based and volume-tiered. The company is privately held and venture-backed, with disclosed funding of approximately ~$2.0–2.3M spanning grants (Temasek Foundation, The Liveability Challenge, Alberta Innovates), angel (Investible), VC (PeakBridge), and accelerator backing (Entrepreneur First, Berkeley SkyDeck, Hatch). Operations span Singapore HQ and a Bangalore, India field operations office supporting South Asia trials and partnerships.

Teora firmographics

Firmographics
Name
Teora
Legal name
Teora Pte. Ltd
Website
https://teoralife.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Teora is a Singapore-based biotech that designs AI-engineered, feed-based oral biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) for aquaculture disease management and growth enhancement, with planned expansion into livestock, poultry, and crops.
Ownership category
akta.pro rank

Teora industry classification

Industry
Product category
Aquaculture Biologics
NAICS
Other Animal Food Manufacturing (311119), Animal Food Manufacturing (3111)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFADADAI
Functional & Health Aquaculture Feed (Immunity, Disease Mitigation)
SECONDARYHLAMAHAF
Aquaculture Feed & Nutrition
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
SECONDARYAFADAGAN
Carrier Systems & Microencapsulated Additive Premixes (Protected Nutrients, Slow-Release)
Agriculture & Food Production/Animal Feed Manufacturing/Feed Premixes & Concentrates (Vitamins, Minerals, Additives)
SECONDARYAFADADAF
Broodstock & Breeder Feed

Keywords

  • Aquaculture animal health
  • Oral biologics platform
  • Feed-based disease prevention
  • Synthetic biology solutions
  • Precision fermentation biologics

Where Teora is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices2 records

Markets served

Teora business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Biologic Product Sales (Aquaculture): Sale of feed-based biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) to aquaculture farmers, feed mills, and distributors. Products are sold as top-coated feed additives or standalone powders. Revenue is transactional with recurring purchase dynamics driven by farm cycle needs.
  2. Licensing Partnerships: Teora offers licensing partnerships for its technology platform, enabling other companies to access SOLAQ™ biologics for specific species, regions, or applications.
  3. Co-Development & Custom Solutions: Custom biologic development partnerships with feed mills, distributors, or large farming operations requiring species or pathogen-specific solutions. Revenue generated through development fees and subsequent product supply.
  4. Distribution & Reseller Revenue: Revenue through distributor and reseller networks that stock and sell Teora biologics to end-user farmers, with margins earned on product throughput.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goVolume-based pricing for smallholder and industrial farms

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Teora product offering

Product offering

Core offering

Teora develops and manufactures disease management and growth enhancement solutions for aquaculture and livestock farming through its proprietary SOLAQ™ AI-powered biotech platform. The platform combines AI-driven bioinformatics, synthetic biology, precision fermentation, and advanced microencapsulation to produce feed-based oral biologics—multi-peptide and microRNA products applied as top-coated feed additives that replace antibiotics, traditional vaccines, and injection-based treatments. Core products include ShrimpGuard™, FishGuard™, FishJumbo™, and ShrimpTrident™ (with variants targeting WSSV, Vibrio, EHP, and IMNV pathogens), sold to shrimp and fish farmers, feed mills, and distributors.

Product overview

Teora offers SOLAQ™, an AI-powered biotech platform that delivers clean, feed-integrated biologics for disease management and growth enhancement across aquaculture, livestock, poultry, companion animals and agriculture. The platform is built around two core product lines: the GUARD SERIES (ShrimpGuard™ and FishGuard™) providing prophylactic disease protection, and the JUMBO SERIES (FishJumbo™) for growth optimization. Additionally, ShrimpTrident variants (SPOT, VIB, EH, MYO) provide targeted therapeutic interventions for specific shrimp pathogens. All products are feed-based, room-temperature stable, antibiotic-free, and designed for direct integration into existing farm operations.

Differentiator

Problem solved

Functional benefit

Brands

  • ShrimpGuard: Feed-based multi-peptide biologic that primes shrimp innate immunity against viral and bacterial challenges including WSSV, IMNV. Available as ShrimpGuard Hatchery and ShrimpGuard Grow-out.
  • FishGuard
  • FishJumbo
  • ShrimpTrident

Quantifiable outcome

  • Up to 90% survival in shrimp farms (vs 0-30% untreated control)
  • +11 more outcomes

Companies that use Teora

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles4 records

Teora technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Teora partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves2 records

Expansion highlights6 records

Teora competitors and assessment

Company assessment

Direct peers

  • Phibro Animal Health: Phibro operates a dedicated aquaculture health portfolio (including vaccines and treatments for shrimp and fish pathogens) sold through similar B2B channels to integrators and feed mills. Teora competes most directly with Phibro's health products in SE Asian shrimp and fish farms.
  • INVE Aquaculture (Benchmark Holdings): INVE offers health and nutrition products for aquaculture hatcheries and grow-out operations, including probiotics and disease-management solutions for shrimp and fish. Like Teora, INVE targets the same species and farm-vertical customers in SE Asia.
  • Lallemand Animal Nutrition: Lallemand provides probiotics, yeast derivatives, and microbial feed additives across aquaculture and livestock, with comparable B2B feed-mill and farmer channel relationships. Teora's peptide and RNAi biologics are a higher-precision alternative to Lallemand's microbial solutions.

Emerging players

  • Veramaris: Veramaris produces alternative, sustainable nutrition ingredients (algal omega-3) for aquaculture feed, addressing similar sustainability and residue-free positioning as Teora. Comparable in being a science-led, feed-based aquaculture solutions company targeting premium feed mills.

Broad incumbents

  • Alltech: Alltech is a global animal nutrition and health company with aquaculture-specific products, including probiotics and feed additives. Teora competes for share of feed-mill biologics and species-specific solutions across the same customer base.
  • Elanco Animal Health: Elanco is a global animal health giant with a substantial aquaculture portfolio including vaccines and therapeutics. As a large incumbent with established regulatory dossiers and distribution, Elanco represents the most credible large-player threat to Teora's positioning.
  • Merck Animal Health (MSD Animal Health): Merck/MSD Animal Health is a global leader in aquaculture vaccines and health products. Comparable in targeting disease management in shrimp and fish but with established scale, capital, and regulatory reach that Teora must compete against.
  • Virbac: Virbac is a global animal health company with aquaculture products spanning vaccines, anti-infectives, and nutrition. Comparable in targeting health outcomes in farmed species through veterinary biologics, but operating at much larger scale.

Others

  • BioMar Group: BioMar is a major aquaculture feed manufacturer that increasingly incorporates health and functional ingredients into its feeds. BioMar is both a potential channel partner and a competitor for functional feed-additive share.
  • Skretting (Nutreco): Skretting is the world's largest aquaculture feed producer with active development of functional and health-focused feed lines. Skretting represents both a major distribution channel opportunity and a potential competitor for premium feed positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Teora social profiles

Digital presence

Teora compliance and trust

Trust signal

Compliance3 records

Teora financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teora leadership team

Management profile

Number of profiles

Profiles5 records

Teora funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teora M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teora

What does Teora do?

Teora develops and manufactures disease management and growth enhancement solutions for aquaculture and livestock farming through its proprietary SOLAQ™ AI-powered biotech platform. The platform combines AI-driven bioinformatics, synthetic biology, precision fermentation, and advanced microencapsulation to produce feed-based oral biologics—multi-peptide and microRNA products applied as top-coated feed additives that replace antibiotics, traditional vaccines, and injection-based treatments. Core products include ShrimpGuard™, FishGuard™, FishJumbo™, and ShrimpTrident™ (with variants targeting WSSV, Vibrio, EHP, and IMNV pathogens), sold to shrimp and fish farmers, feed mills, and distributors.

Is Teora a public or private company?

Teora is a private company. It is classified as venture growth investor backed and is currently operating.

When was Teora founded?

Teora was founded in 2020. It employs 11 to 50 people.

Where is Teora based?

Teora is headquartered in Singapore, Singapore, in the Asia region.

How does Teora make money?

Four revenue lines are on record. Biologic Product Sales (Aquaculture) is the primary driver. The others are licensing Partnerships, co-Development & Custom Solutions and distribution & Reseller Revenue.

Who are Teora's main competitors?

Direct peers on record are Phibro Animal Health, INVE Aquaculture (Benchmark Holdings) and Lallemand Animal Nutrition. Veramaris is listed as an emerging player. Broad incumbents are Alltech, Elanco Animal Health, Merck Animal Health (MSD Animal Health) and Virbac. Others are BioMar Group and Skretting (Nutreco).

Does Teora have an API?

No public API is recorded for Teora.

What industry is Teora in?

Teora's product category is Aquaculture Biologics. Its primary akta.pro industry code is AFADADAI, Functional & Health Aquaculture Feed (Immunity, Disease Mitigation), with a secondary code of HLAMAHAF, Aquaculture Feed & Nutrition. Its NAICS code is 311119 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Business TimesA safer way to save farmed fishSingaporean biotech startup TeOra has secured S$1 million in grant funding and a S$100,000 investment from PeakBridge VC to develop oral biological vaccines for farmed fish. The company aims to use these funds to advance testing and certification of its technology, which targets diseases like the virus causing scale loss in Asian seabass.InvestibleInvestment Notes: TeOraThe article discusses an investment in TeOra, a Singaporean startup focused on developing oral vaccines to reduce food loss in aquaculture, particularly targeting the White Spot disease affecting shrimp. TeOra's innovative delivery method has demonstrated a survival rate of 78% for infected shrimp, addressing a significant challenge in the aquaculture industry. This solution has the potential to scale and positively impact food security while reducing greenhouse gas emissions.The Fish SiteEight aquaculture startups vie for $1.6 million in prizesEight aquaculture startups were selected from 180 applications for a $1.6 million prize challenge. The finalists include Feedvax, Genufeed, Jala, Salmokine, Seawater Solutions, TeOra, Wittaya Aqua, and Xylome, representing innovations in health, water quality, nutrition, and farming technology. The challenge culminates in a pitch event on 7 October.The Business TimesTalent investor Entrepreneur First unveils latest batch of deep techsEntrepreneur First unveiled its sixth cohort of 19 deep tech startups from Singapore, Bangalore, and Hong Kong. The investor day was cancelled due to Covid-19 concerns, and startups will pitch directly. The program has helped over 600 co-founders build more than 120 companies.